• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去分化、转分化和细胞融合:再生医学中的体内重编程策略。

Dedifferentiation, transdifferentiation and cell fusion: in vivo reprogramming strategies for regenerative medicine.

机构信息

Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Spain.

Universitat Pompeu Fabra (UPF), Barcelona, Spain.

出版信息

FEBS J. 2019 Mar;286(6):1074-1093. doi: 10.1111/febs.14633. Epub 2018 Aug 27.

DOI:10.1111/febs.14633
PMID:30103260
Abstract

Regenerative capacities vary enormously across the animal kingdom. In contrast to most cold-blooded vertebrates, mammals, including humans, have very limited regenerative capacity when it comes to repairing damaged or degenerating tissues. Here, we review the main mechanisms of tissue regeneration, underlying the importance of cell dedifferentiation and reprogramming. We discuss the significance of cell fate and identity changes in the context of regenerative medicine, with a particular focus on strategies aiming at the promotion of the body's self-repairing mechanisms. We also introduce some of the most recent advances that have resulted in complete reprogramming of cell identity in vivo. Lastly, we discuss the main challenges that need to be addressed in the near future to develop in vivo reprogramming approaches with therapeutic potential.

摘要

再生能力在动物界差异巨大。与大多数冷血脊椎动物不同,哺乳动物,包括人类,在修复受损或退化组织方面的再生能力非常有限。在这里,我们综述了组织再生的主要机制,强调了细胞去分化和重编程的重要性。我们讨论了细胞命运和身份变化在再生医学背景下的意义,特别关注旨在促进身体自我修复机制的策略。我们还介绍了一些最近的进展,这些进展导致了体内细胞身份的完全重编程。最后,我们讨论了在不久的将来需要解决的主要挑战,以开发具有治疗潜力的体内重编程方法。

相似文献

1
Dedifferentiation, transdifferentiation and cell fusion: in vivo reprogramming strategies for regenerative medicine.去分化、转分化和细胞融合:再生医学中的体内重编程策略。
FEBS J. 2019 Mar;286(6):1074-1093. doi: 10.1111/febs.14633. Epub 2018 Aug 27.
2
Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine.去分化、转分化和重编程:再生医学的未来方向。
Semin Reprod Med. 2013 Jan;31(1):82-94. doi: 10.1055/s-0032-1331802. Epub 2013 Jan 17.
3
Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration.去分化、转分化和重编程:三种再生途径。
Nat Rev Mol Cell Biol. 2011 Feb;12(2):79-89. doi: 10.1038/nrm3043.
4
Reprogramming and transdifferentiation shift the landscape of regenerative medicine.重编程和转分化改变了再生医学的格局。
DNA Cell Biol. 2013 Oct;32(10):565-72. doi: 10.1089/dna.2013.2104. Epub 2013 Aug 9.
5
Chemical transdifferentiation: closer to regenerative medicine.化学转分化:更接近再生医学
Front Med. 2016 Jun;10(2):152-65. doi: 10.1007/s11684-016-0445-z. Epub 2016 May 3.
6
Strategies for in vivo reprogramming.体内重编程策略。
Curr Opin Cell Biol. 2019 Dec;61:9-15. doi: 10.1016/j.ceb.2019.06.002. Epub 2019 Jul 16.
7
Engineering Cell Fate for Tissue Regeneration by In Vivo Transdifferentiation.通过体内转分化工程化细胞命运以实现组织再生
Stem Cell Rev Rep. 2016 Feb;12(1):129-39. doi: 10.1007/s12015-015-9624-6.
8
A Revolution in Reprogramming: Small Molecules.重编程的革命:小分子。
Curr Mol Med. 2019;19(2):77-90. doi: 10.2174/1566524019666190325113945.
9
Natural and induced direct reprogramming: mechanisms, concepts and general principles-from the worm to vertebrates.自然与诱导直接重编程:从线虫到脊椎动物的机制、概念及一般原则
Curr Opin Genet Dev. 2016 Oct;40:154-163. doi: 10.1016/j.gde.2016.06.014. Epub 2016 Sep 28.
10
Cell-fusion-mediated reprogramming: pluripotency or transdifferentiation? Implications for regenerative medicine.细胞融合介导的重编程:多能性还是转分化?对再生医学的影响。
Adv Exp Med Biol. 2011;713:137-59. doi: 10.1007/978-94-007-0763-4_9.

引用本文的文献

1
Efficient Fabrication of Human Corneal Stromal Cell Spheroids and Promoting Cell Stemness Based on 3D-Printed Derived PDMS Microwell Platform.基于3D打印衍生的聚二甲基硅氧烷微孔平台高效制备人角膜基质细胞球体并促进细胞干性
Biomolecules. 2025 Mar 19;15(3):438. doi: 10.3390/biom15030438.
2
Current advances and future prospects of cell reprogramming in progeroid syndromes.早衰综合征中细胞重编程的当前进展与未来前景
Front Cell Dev Biol. 2025 Feb 19;13:1546423. doi: 10.3389/fcell.2025.1546423. eCollection 2025.
3
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.
去分化过程驱动的表观遗传改变中肺癌干细胞的分子特征。
J Biol Chem. 2024 Dec;300(12):107994. doi: 10.1016/j.jbc.2024.107994. Epub 2024 Nov 14.
4
Engineered Mitochondrial Transplantation as An Anti-Aging Therapy.工程化线粒体移植作为一种抗衰老疗法
Aging Dis. 2024 Jul 19. doi: 10.14336/AD.2024.0231.
5
Bacterial Ribosomes Induce Plasticity in Mouse Adult Fibroblasts.细菌核糖体诱导成年小鼠成纤维细胞发生可塑性。
Cells. 2024 Jun 27;13(13):1116. doi: 10.3390/cells13131116.
6
Annelids as models of germ cell and gonad regeneration.环节动物作为生殖细胞和性腺再生的模型。
J Exp Zool B Mol Dev Evol. 2024 May;342(3):126-143. doi: 10.1002/jez.b.23233. Epub 2023 Dec 11.
7
Mitochondrial transfer in hematological malignancies.血液系统恶性肿瘤中的线粒体转移
Biomark Res. 2023 Oct 5;11(1):89. doi: 10.1186/s40364-023-00529-x.
8
Transit Amplifying Cells (TACs): a still not fully understood cell population.过渡放大细胞(TACs):一种仍未被完全理解的细胞群体。
Front Bioeng Biotechnol. 2023 May 9;11:1189225. doi: 10.3389/fbioe.2023.1189225. eCollection 2023.
9
Mitochondrial transfer/transplantation: an emerging therapeutic approach for multiple diseases.线粒体转移/移植:一种新兴的针对多种疾病的治疗方法。
Cell Biosci. 2022 May 19;12(1):66. doi: 10.1186/s13578-022-00805-7.
10
EGF signaling promotes the lineage conversion of astrocytes into oligodendrocytes.表皮生长因子(EGF)信号传导促进星形胶质细胞向少突胶质细胞的谱系转换。
Mol Med. 2022 May 4;28(1):50. doi: 10.1186/s10020-022-00478-5.